The ACI department is dedicated to developing noninvasive technologies for molecular-resolution imaging. Through these technologies, vulnerable plaques can be identified and characterized, providing invaluable information on the underlying molecular mechanisms of disease and leading to tools for accurate diagnosis and targeted drug delivery.